Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis

被引:38
作者
Graham, Nicola [1 ]
Qian, Bin-Zhi [1 ,2 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XR, Midlothian, Scotland
基金
欧洲研究理事会;
关键词
bone; metastasis; tumor microenvironment; stromal cells; mesenchymal stem cells; cancer-associated fibroblasts; metastatic niche; dormancy; BREAST-CANCER CELLS; HEMATOPOIETIC STEM-CELLS; HEPATOCYTE GROWTH-FACTOR; DISSEMINATED TUMOR-CELLS; PROSTATE-CANCER; ANNEXIN-II; PROGENITOR CELLS; IN-VIVO; CHEMOKINE RECEPTORS; MYELOMA CELLS;
D O I
10.3390/ijms19041121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Bone metastasis is the most advanced stage of many cancers and indicates a poor prognosis for patients due to resistance to anti-tumor therapies. The establishment of metastasis within the bone is a multistep process. To ensure survival within the bone marrow, tumor cells must initially colonize a niche in which they can enter dormancy. Subsequently, reactivation permits the proliferation and growth of the tumor cells, giving rise to a macro-metastasis displayed clinically as a bone metastatic lesion. Here, we review the evidences that suggest mesenchymal stromal cells play an important role in each of these steps throughout the development of bone metastasis. Similarities between the molecular mechanisms implicated in these processes and those involved in the homeostasis of the bone indicate that the metastatic cells may exploit the homeostatic processes to their own advantage. Identifying the molecular interactions between the mesenchymal stromal cells and tumor cells that promote tumor development may offer insight into potential therapeutic targets that could be utilized to treat bone metastasis.
引用
收藏
页数:34
相关论文
共 285 条
[1]
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial [J].
Aft, Rebecca ;
Naughton, Michael ;
Trinkaus, Kathryn ;
Watson, Mark ;
Ylagan, Lourdes ;
Chavez-MacGregor, Mariana ;
Zhai, Jing ;
Kuo, Socha ;
Shannon, William ;
Diemer, Kathryn ;
Herrmann, Virginia ;
Dietz, Jill ;
Ali, Amjad ;
Ellis, Matthew ;
Weiss, Peter ;
Eberlein, Timothy ;
Ma, Cynthia ;
Fracasso, Paula M. ;
Zoberi, Imran ;
Taylor, Marie ;
Gillanders, William ;
Pluard, Timothy ;
Mortimer, Joanne ;
Weilbaecher, Katherine .
LANCET ONCOLOGY, 2010, 11 (05) :421-428
[2]
Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo [J].
Aguirre-Ghiso, JA ;
Liu, D ;
Mignatti, A ;
Kovalski, K ;
Ossowski, L .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) :863-879
[3]
Therapeutic angiogenesis using autologous bone marrow stromal cells: Improved blood flow in a chronic limb ischemia model [J].
Al-Khaldi, A ;
Al-Sabti, H ;
Galipeau, J ;
Lachapelle, K .
ANNALS OF THORACIC SURGERY, 2003, 75 (01) :204-209
[4]
Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone [J].
Aldridge, SE ;
Lennard, TWJ ;
Williams, JR ;
Birch, MA .
BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1531-1537
[5]
Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[6]
Role of the metastasis-promoting protein osteopontin in the tumour microenvironment [J].
Anborgh, Pieter H. ;
Mutrie, Jennifer C. ;
Tuck, Alan B. ;
Chambers, Ann F. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (08) :2037-2044
[7]
[Anonymous], P NATL ACAD SCI US
[8]
[Anonymous], 2012, CANCER
[9]
[Anonymous], BONEKEY REP
[10]
[Anonymous], 2015, CELL BIOSCI